Supplementary Methods

Quantile normalization of BAF
In the analysis of next-generation sequencing data, there is a loss of reads (LOR) issue encountered in the alignment step of mapping reads to reference genome (Kim, et al., 2013) . The preference of existing aligner, such as BioScope and BWA (Li and Durbin, 2009) , for aligning reads to reference allele over to the alternative allele makes BAF plots are asymmetrically positioned around 0.5. We use tQN (Staaf, et al., 2008) proposed by Johan Staaf to normalize BAF signals.
Let vector N b : 1 and N T : 1 denote the number of reads aligned to non-reference base and the total number of reads of N SNP positions respectively, and BAF is defined as:
The reference allele frequency can be easily calculated as:
The BAF and RAF signals should theoretically follow same distribution, which is the core idea of quantile normalization. The detailed description of the process of quantile normalization (QN) can be found in (Bolstad, et al., 2003) . A threshold of 0.9 is used in this study for the tQN of BAF and RAF.
Let NB denotes the quantile normalized B allele frequency. Suppose that there are i d reads sequenced from alternative chromosome and wrongly discarded by aligner for i th SNP position, and the corrected N b : 1 and N T : 1 can be written as:
We can simply define an equation between i d and i NB as follows:
1.2. Integrated Hidden Markov Model
Hidden state space
The hidden state space consists of 20 states with different copy number status and tumor genotype (Table   S1 ). Copy number up to 7 is considered in our model. Each state in HMM corresponds to a copy number status. For example, state 1 is the case of deletion of two copies, state 5 is the case that the copy number is three with duplication of one allele and state 8 is the case that copy number is four with equal duplication of two alleles.
Emission model
The probability distribution functions of read counts data and RD data can be found in main text.
We incorporate the effect of signal fluctuation in the emission models of CLImAT, and in this case a uniform distribution is employed to approximate the statistical distributions of B allele read count and RD:
Parameter estimation
We employed the expectation maximization (EM) algorithm for parameter estimation. In the expectation step, we use only heterozygous tumor genotypes included in each state to calculate the expectation of the partial log-likelihood of BAF, which is formulated as:
Forward-backward algorithm (Rabiner, 1989 ) is used to calculate the posterior probability   c i  that the i th SNP to be in state c. Similarly, the expectation of the partial log-likelihood function of RD data is formulated as: with respect to each of the involved parameters is derived. The update process for all the parameters is shown as following.
For estimation of the parameter of tumor impurity level s w , we use both BAF and RD signals. 
Where the  function, also known as the digamma function, is the logarithmic derivative of the gamma function. We update the parameter s w for the next iteration using the following formula:
Next, we use the updated parameter s w to further update other parameters. The update process for the parameter of copy neutral read count  is taken as below: 
When  is updated, the parameter o and c p are updated in the same way.
We use the approach discussed in ref. (Rabiner, 1989) to estimate the initial state distribution  and state transition matrix A. The EM algorithm for CLImAT is implemented as follows: (1) start with initial
using the aforementioned method, (3) repeat steps (1) and (2) until the algorithm converges. Finally, the parameters in the last iteration of the training process will be displayed as the optimal estimators. At the same time, copy number, tumor genotype and zygosity state for each SNP can be inferred from the hidden state associated with the largest posterior probability. Moreover, we perform a simple grid search of these parameters to find optimal initial parameters, which are necessary for model training.
Post-processing procedure for copy number annotation
Due to the limited number of hidden states, the maximal copy number detected by the HMM is 7. In some particular cases, it is of interest to examine the exact number of an extremely amplified region, which may be implicated in tumor aggressiveness. Therefore, in CLImAT a post-processing procedure is performed for copy number annotation of highly amplified regions (copy number >7) by using the following equation:
here m rd is the mean of RD values, function round() takes the nearest integer. To further improve the resolution of CLImAT, we also provide an option ("distSNPs_est") in configuration file to estimate copy number for the regions between distant SNPs (>1kb) by calculating the corresponding RD signals. Each region is divided into non-overlapping and equally sized windows (1kb) and the calculated RD signal is further smoothed by a local median filter. Then copy number of each window is calculated according to RD signal by using formula (25).
Reliability score for aberration detection
It is important to provide a measurement for users to evaluate the reliability of CLImAT results. For a genomic region with tumor heterogeneity, the BAF/RD signals do not fit to the HMM used in CLImAT and therefore the posterior probabilities of the heterogeneous region should be much lower than those of homogeneous regions, which inspire us to use the posterior probabilities of observed BAF/RD signals to measure reliability. It is also preferable to divide the posterior probabilities of BAF/RD signals by the probabilities of expected BAF/RD signals to make reliability scores comparable among different hidden states in the HMM. Accordingly, we define a reliability score for each aberrant region in the results as follows: c. Furthermore, for illustration the scores for all regions detected along the cancer genome are scaled to 0~100.
Performance evaluation
We adopt the performance evaluation procedure proposed in APOLLOH (Ha, et al., 2012) , in which all the calls of the informative (heterozygous) positions are used as the golden standard to compare the abilities of different computational methods in detecting genomic aberrations. Accordingly, for simulated tumor samples the CNA/LOH calls of all heterozygous positions pre-determined in tumor-normal admixture experiment (see Figure S1 and Section 1.6 for more detailed information) are treated as the ground truth. For 
The results generated by all investigated methods for performance evaluation and the detailed information on all evaluated genomic positions in TNBC samples are provided at http://bioinformatics.ustc.edu.cn/ CLImAT/download.html.
Tumor-normal admixture experiment
Tumor-normal admixture simulation experiment is performed on chromosome 20 of human reference (NCBI build 36, hg18) by sampling reads from a control genome and a test genome under different predefined parameters ( Figure S1 ). The test genome is constructed according to predefined HMM state sequence with different copy number and BAF values. First, the control genome is divided into non-overlapping and equally sized segments (up to 20 segments are generated), and each segment is randomly assigned a hidden state of the HMM used in CLImAT. Similar to method used in previous study (Duan, et al., 2013) , for a segment with copy number n and BAF value b, we generate n copies of the segment with SNP information added to each sequences according to the BAF value ( Figure S1 ), we joint n-1 sequences to construct a new segment and replace the original segment on one chain with the new one.
After the test genome has been generated, tumor-normal admixture experiment is performed under different tumor impurity level. Assuming that the length of control genome and test genome are c L and t L respectively, the length of read is l, and the level of tumor impurity is s w , for a depth of coverage c, the number of reads need to be sampled is l
. The number of reads sampled from control genome can be empirically calculated as follows:
The number of reads sampled from test genome is
GC-content is one of the main factors that influence the depth of coverage. To simplify the form of GC-content effect on read count, we use a simple probability model to describe the sampling process,
, the probability that a read could be sampled from a window with GC-percentage i GC (0,1,2,…,100). The probability distribution  
is learned from real TNBC sample 1 using 2-copy regions. For a GC-percentage j, we get median read count (RC) of all windows that have the same
is calculated as follows:
is further normalized along the genome:
Here W is the number of windows. In the sampling process, the control and test genome are first divided into non-overlapping and equally sized windows (1000bp), and GC-percentage is calculated for each of the windows. For a window i, the number of sampled reads that start within the window can be simply obtained as follows:
Here g N is the total number of reads sampled from the whole genome. We randomly chose i RN positions from window i as the start positions of the reads and then sample the reads from the genome.
All the reads sampled from both control and test genomes are aligned to chromosome 20 of human reference (hg18) using Bowtie (Langmead, et al., 2009) , BAM files and pileups are generated using SAMtools (Li, et al., 2009 ).
To evaluate the reliability score for aberration detection described in Section 1.4, we further generate heterogeneous tumor data containing cancer subclones using simulated diploid tumor sample with tumor impurity level of 0.2. In region I ( Figure S10 ), we assume there are two subclones with corresponding proportion of 0.24 and 0.56, respectively. Specifically, subclone 1 has copy number of 3 with minor copy number of 1 and subclone 2 has copy number of 4 with minor copy number of 1. We adjust the means of RD and BAF values in region I by using extensions to Equations (3) and (4) (Carter, et al., 2012) takes user-generated segmentation file as input and outputs inferred tumor purity and ploidy. We test ABSOLUTE on simulated samples. For each pair of tumor-normal samples, the segmentation file is generated using the method proposed in THetA (Oesper, et al., 2013) .
ABSOLUTE returns three kinds of solutions: (1) Solutions based on somatic copy number aberrations (SCNA); (2) Solutions based on recurrent Karyotypes; and (3) Solutions based on combination of SCNAs and Karyotypes. We used the default solution returned by ABSOLUTE as the final solution.
When running ABSOLUTE on simulated samples, we set the maximal possible ploidy to the maximal copy number in the simulated data rather than the default value of 10. All other parameters are set to their default values as described in the ABSOLUTE documentation.
SNVMix
SNVMix (version 2-0.11) (Goya, et al., 2010) is a tool to predict single nucleotide variants from next-generation sequencing of tumors. When running SNVMix, we use the model parameter file provided at the SNVMix website: http://compbio.bccrc.ca/software/snvmix/.
FREEC
FREEC (version 6.7) (Boeva, et al., 2012; Boeva, et al., 2011) is one of the widely adopted tools to call CNA and LOH from next-generation sequencing data. FREEC can deal with either unpaired tumor samples or paired tumor-normal samples. In this study, we run FREEC on unpaired tumor samples, we use the following parameters: Patchwork (version 2.4) (Mayrhofer, et al., 2013) Relationship between RD and GC-Content/mappability is fitted by a cubic polynomial curve for each P-copy region, and the results of the least-square fit for 1-copy, 2-copy and 3-copy are shown in black. Results for triploid tumor samples. BAF is presented by five different aberration states: homozygous deletion (HOMD), hemizygous deletion (HEMD), heterozygous (HET), copy neutral LOH (NLOH) and amplified LOH (ALOH). LRR/RD is presented by homozygous deletion (HOMD), hemizygous deletion (HEMD), neutral (NEUT) and amplification (AMP). The left labels show the level of tumor impurity, for example "T90N10" denotes that tumor impurity level is 0.1 with 90%tumor and 10% normal cells. S10 . Reliability scores for simulated tumor data containing two cancer subclones. Subclone 1 has copy number of 3 and subclone 2 has copy number of 4 in region I. For other regions both subclones share the same copy number. The reliability score of region I is significantly lower than those of other regions, for the reason that the BAF/RD signals in region I do not fit to the HMM. 
